Postoperative pneumonia in patients with non-small cell lung cancer undergoing thoracoscopic surgery: What should we care about?

BackgroundThe prevention of postoperative pneumonia in patients with non-small cell lung cancer (NSCLC) undergoing thoracoscopic surgery holds significant clinical importance. This study aimed to evaluate the status quo and influencing factors of postoperative pneumonia in patients with NSCLC.Method...

Full description

Saved in:
Bibliographic Details
Main Authors: Jinzhi You, Dandan Chen, Xiang Liu, Hailing Zhang, Zhongfeng Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1564042/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849418815640698880
author Jinzhi You
Dandan Chen
Xiang Liu
Hailing Zhang
Zhongfeng Zheng
author_facet Jinzhi You
Dandan Chen
Xiang Liu
Hailing Zhang
Zhongfeng Zheng
author_sort Jinzhi You
collection DOAJ
description BackgroundThe prevention of postoperative pneumonia in patients with non-small cell lung cancer (NSCLC) undergoing thoracoscopic surgery holds significant clinical importance. This study aimed to evaluate the status quo and influencing factors of postoperative pneumonia in patients with NSCLC.MethodsPatients with NSCLC undergoing thoracoscopic surgery at our hospital from January 2023 to October 2024 were included. The characteristics of patients with and without postoperative pneumonia were analyzed. A logistic regression model was employed to analyze the influencing factors of postoperative pneumonia, and a corresponding predictive model was constructed. The predictive performance of the model was evaluated using receiver operating characteristic (ROC) curve analysis.ResultsA total of 226 patients with NSCLC were included, the incidence of postoperative pneumonia in patients with NSCLC was 31.86%. Correlation analyses showed that age(r=0.570), scope of the surgical procedure(r=0.618), COPD(r=0.562), history of smoking(r=0.516) and hypoproteinemia(r=0.587) were associated with the occurrence of postoperative pneumonia. Logistic regression analysis revealed that age (OR=2.146, 95%CI: 1.439~3.045), scope of the surgical procedure (OR=3.009, 95%CI: 2.813~3.543), COPD (OR=2.312, 95%CI: 1.605~3.008), history of smoking (OR=2.445, 95%CI: 2.117~2.821) and hypoproteinemia(OR=1.997, 95%CI: 1.533~2.580) were the independent influencing factors of postoperative pneumonia in patient with NSCLC. The area under the ROC curve (AUC) was 0.830.ConclusionThe incidence of postoperative pneumonia in patients with NSCLC is relatively high and is influenced by a multitude of factors. The postoperative pneumonia risk prediction model developed in this study has demonstrated promising predictive performance. However, given the single-center design and limited sample size, additional clinical validation is necessary to confirm its practical applicability and reliability in real-world clinical settings.
format Article
id doaj-art-5b433bd5f57b4e699df1eaab073ffd2a
institution Kabale University
issn 2234-943X
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-5b433bd5f57b4e699df1eaab073ffd2a2025-08-20T03:32:19ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-06-011510.3389/fonc.2025.15640421564042Postoperative pneumonia in patients with non-small cell lung cancer undergoing thoracoscopic surgery: What should we care about?Jinzhi You0Dandan Chen1Xiang Liu2Hailing Zhang3Zhongfeng Zheng4Department of Thoracic Surgery, The Affiliated Suqian Hospital of Xuzhou Medical University, Suqian, Jiangsu, ChinaDepartment of Gastroenterology, The Affiliated Suqian First People’s Hospital of Nanjing Medical University, Suqian, Jiangsu, ChinaDepartment of Thoracic Surgery, The Affiliated Suqian Hospital of Xuzhou Medical University, Suqian, Jiangsu, ChinaDepartment of Gastroenterology, The Affiliated Suqian First People’s Hospital of Nanjing Medical University, Suqian, Jiangsu, ChinaDepartment of Thoracic Surgery, The Affiliated Suqian Hospital of Xuzhou Medical University, Suqian, Jiangsu, ChinaBackgroundThe prevention of postoperative pneumonia in patients with non-small cell lung cancer (NSCLC) undergoing thoracoscopic surgery holds significant clinical importance. This study aimed to evaluate the status quo and influencing factors of postoperative pneumonia in patients with NSCLC.MethodsPatients with NSCLC undergoing thoracoscopic surgery at our hospital from January 2023 to October 2024 were included. The characteristics of patients with and without postoperative pneumonia were analyzed. A logistic regression model was employed to analyze the influencing factors of postoperative pneumonia, and a corresponding predictive model was constructed. The predictive performance of the model was evaluated using receiver operating characteristic (ROC) curve analysis.ResultsA total of 226 patients with NSCLC were included, the incidence of postoperative pneumonia in patients with NSCLC was 31.86%. Correlation analyses showed that age(r=0.570), scope of the surgical procedure(r=0.618), COPD(r=0.562), history of smoking(r=0.516) and hypoproteinemia(r=0.587) were associated with the occurrence of postoperative pneumonia. Logistic regression analysis revealed that age (OR=2.146, 95%CI: 1.439~3.045), scope of the surgical procedure (OR=3.009, 95%CI: 2.813~3.543), COPD (OR=2.312, 95%CI: 1.605~3.008), history of smoking (OR=2.445, 95%CI: 2.117~2.821) and hypoproteinemia(OR=1.997, 95%CI: 1.533~2.580) were the independent influencing factors of postoperative pneumonia in patient with NSCLC. The area under the ROC curve (AUC) was 0.830.ConclusionThe incidence of postoperative pneumonia in patients with NSCLC is relatively high and is influenced by a multitude of factors. The postoperative pneumonia risk prediction model developed in this study has demonstrated promising predictive performance. However, given the single-center design and limited sample size, additional clinical validation is necessary to confirm its practical applicability and reliability in real-world clinical settings.https://www.frontiersin.org/articles/10.3389/fonc.2025.1564042/fullpneumonialung cancersurgerytreatmentcareclinical
spellingShingle Jinzhi You
Dandan Chen
Xiang Liu
Hailing Zhang
Zhongfeng Zheng
Postoperative pneumonia in patients with non-small cell lung cancer undergoing thoracoscopic surgery: What should we care about?
Frontiers in Oncology
pneumonia
lung cancer
surgery
treatment
care
clinical
title Postoperative pneumonia in patients with non-small cell lung cancer undergoing thoracoscopic surgery: What should we care about?
title_full Postoperative pneumonia in patients with non-small cell lung cancer undergoing thoracoscopic surgery: What should we care about?
title_fullStr Postoperative pneumonia in patients with non-small cell lung cancer undergoing thoracoscopic surgery: What should we care about?
title_full_unstemmed Postoperative pneumonia in patients with non-small cell lung cancer undergoing thoracoscopic surgery: What should we care about?
title_short Postoperative pneumonia in patients with non-small cell lung cancer undergoing thoracoscopic surgery: What should we care about?
title_sort postoperative pneumonia in patients with non small cell lung cancer undergoing thoracoscopic surgery what should we care about
topic pneumonia
lung cancer
surgery
treatment
care
clinical
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1564042/full
work_keys_str_mv AT jinzhiyou postoperativepneumoniainpatientswithnonsmallcelllungcancerundergoingthoracoscopicsurgerywhatshouldwecareabout
AT dandanchen postoperativepneumoniainpatientswithnonsmallcelllungcancerundergoingthoracoscopicsurgerywhatshouldwecareabout
AT xiangliu postoperativepneumoniainpatientswithnonsmallcelllungcancerundergoingthoracoscopicsurgerywhatshouldwecareabout
AT hailingzhang postoperativepneumoniainpatientswithnonsmallcelllungcancerundergoingthoracoscopicsurgerywhatshouldwecareabout
AT zhongfengzheng postoperativepneumoniainpatientswithnonsmallcelllungcancerundergoingthoracoscopicsurgerywhatshouldwecareabout